Medtronic (MDT) Amortization of Deferred Charges (2015 - 2018)

Medtronic has disclosed Amortization of Deferred Charges across 4 years of filings, most recently posting $4.0 million for Q2 2018.

• Amortization of Deferred Charges for Q2 2018 came in at $4.0 million, up 140.0% year-over-year; the trailing twelve-month figure through Apr 2018 was -$13.0 million (down 218.18% YoY), and the FY2018 annual result was -$13.0 million, down 218.18% from the prior year.
• Amortization of Deferred Charges came in at $4.0 million for Q2 2018 at Medtronic, up from $3.0 million in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $8.0 million in Q4 2015 to a low of -$10.0 million in Q2 2017.
• The 4-year median for Amortization of Deferred Charges is $7.0 million (2015), against an average of $2.2 million.
• Across the five-year window, Amortization of Deferred Charges sank 242.86% in 2017 and jumped 140.0% in 2018, its largest moves.
• Medtronic's Amortization of Deferred Charges stood at $8.0 million in 2015, then declined by 12.5% to $7.0 million in 2016, then tumbled by 242.86% to -$10.0 million in 2017, then surged by 140.0% to $4.0 million in 2018.
• The last three Amortization of Deferred Charges figures came in at $4.0 million (Q2 2018), $3.0 million (Q1 2018), and -$10.0 million (Q4 2017), per Business Quant data.